ÂÜÀòÂÒÂ×

Lynn Phelan possesses extensive experience in the pharmaceutical and vaccine development fields, particularly within Pfizer and Wyeth. As Vice President of Pfizer Vaccines, Lynn led a team of over 150 scientists in early bioprocess development, focusing on manufacturing processes and formulations for vaccines. Previous roles included Associate Director and Senior Director in Analytical Development at Wyeth, managing analytical laboratories and contributing to drug substance and product development through method validation and regulatory documentation. Lynn's expertise encompasses a spectrum of analytical methodologies and formulation development for various vaccine types, including mRNA and protein-based vaccines. Educational credentials include a B.S. in Chemistry from Binghamton University and a Ph.D. in Chemistry from Princeton University.